Low Energy Diets for Obesity and CKD (SLOW-CKD Randomized Feasibility Study)

Metabolic Health
Metabolic Health
  • 08/04/2026 - 12:00 am

This study by Conley M et al. investigates the safety and feasibility of VLEDs in adults with obesity and CKD, offering fresh insights into how structured VLED programs and dietitian intervention—may support weight loss and potentially slow CKD progression.

Other content you might be interested in
lesson1
Metabolic Health
Metabolic Health

CPD Academy 1 LESSON

Optimising Nutrition During GLP-1 RA Therapy for Weight Loss

In this education module, learn from expert metabolic health GP and dietitian Dr Terri-Lynne South on the nutritional risks, considerations and optimal dietary intake for patients on GLP-1 RA therapy for weight loss. ​ Learning Objectives:​ Identify the nutritional risks associated with GLP-1 RA therapy for weight loss​ Summarise the nutritional requirements to be considered for individuals on GLP-1 RA therapy ​ Outline how to optimise the nutrition of your patients who are prescribed GLP-1 RAs

Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement
Metabolic Health
Metabolic Health

EXTERNAL LINK

Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement

This publication provides 52 consensus recommendations by an expert panel on nutrition and lifestyle support for people using GLP‑1–based obesity therapies, addressing weight management, body composition, and common GI symptoms.